Pulmatrix在合并前的市值仅为七百多万美元，合并公告一出，市值立马接近翻倍，达到1300万美元。从后期股权分配以及企业规模来看，睿跃生物很明显占有着主导权，那么合并之后的公司，未来又将是怎样的走向？

引言淀粉样蛋白（amyloid）一直是一个备受关注的研究课题，其异常堆积与多种严重疾病密切相关。近年来，研究人员在治疗淀粉样蛋白相关疾病方面取得了显著进展，尤其在心力衰竭、肌萎缩侧索硬化症（ALS）以及阿尔茨海默病（Alzheimer's ...

Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...

Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

Boston has become one of the top places for biotech research, and one of the big players in this space is CRISPR gene-editing ...

Spanish biotech Integra Therapeutics has upped its arsenal of gene editing tools by licensing Caszyme’s Cas12I nucleases, the ...

Biotech valuations and investing peaked in late 2021, with investors surging into the sector at the height of the Covid-19 ...

A Seattle biotech company is working on a tweak to gene expression that could shut down hepatitis B (HBV), one of the viruses ...

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...

GenScript Biotech Corporation ("GenScript"), a global leader in life sciences services and products, has announced the establishment of new operations site and logistics center in Sydney, Australia.

Successfully navigating a drug development cycle is a major undertaking. On average, the sequence takes over a decade to ...